Authors:
Yang, W
Shen, J
Wu, M
Arsura, M
FitzGerald, M
Suldan, Z
Kim, DW
Hofmann, CS
Pianetti, S
Romieu-Mourez, R
Freedman, LP
Sonenshein, GE
Citation: W. Yang et al., Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc, ONCOGENE, 20(14), 2001, pp. 1688-1702
Authors:
Pianetti, S
Arsura, M
Romieu-Mourez, R
Coffey, RJ
Sonenshein, GE
Citation: S. Pianetti et al., Her-2/neu overexpression induces NF-kappa B via a PI3-kinase/Akt pathway involving calpain-mediated degradation of I kappa-B-alpha that can be inhibited by the tumor suppressor PTEN, ONCOGENE, 20(11), 2001, pp. 1287-1299
Authors:
Romieu-Mourez, R
Landesman-Bollag, E
Seldin, DC
Traish, AM
Mercurio, F
Sonenshein, GE
Citation: R. Romieu-mourez et al., Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappa B in breast cancer, CANCER RES, 61(9), 2001, pp. 3810-3818
Authors:
Kim, DW
Gazourian, L
Quadri, SA
Romieu-Mourez, R
Sherr, DH
Sonenshein, GE
Citation: Dw. Kim et al., The RelA NF-kappa B subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells, ONCOGENE, 19(48), 2000, pp. 5498-5506
Authors:
Kim, DW
Sovak, MA
Zanieski, G
Nonet, G
Romieu-Mourez, R
Lau, AW
Hafer, LJ
Yaswen, P
Stampfer, M
Rogers, AE
Russo, J
Sonenshein, GE
Citation: Dw. Kim et al., Activation of NF-kappa B/Rel occurs early during neoplastic transformationof mammary cells, CARCINOGENE, 21(5), 2000, pp. 871-879